NEW YORK (GenomeWeb News) – Merck KGaA subsidiary EMD Chemicals yesterday said that it will work with MitoSciences to develop assays for drug toxicity and mitochondrial bioactivity.

The firms intend to co-develop multiplex immunoassay products for EMD's WideScreen BeadPlex assay platform for detecting and profiling mitochondrial toxicity and activity. The WideScreen assays run on a Luminex xMAP system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.